Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.55 |
| ▸ | DRD2 | P14416 | 4/20 | 0.44 |
| ▸ | DRD3 | P35462 | 3/20 | 0.44 |
| ▸ | DRD4 | P21917 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5275161 | 0.83 | ACHE (0.73) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL7665918 | 0.80 | LMNA (0.49) | MAPTKDM4ELMNAPOLBACHE | |
| Hydrochloric Acid SCHEMBL7272487 | 0.80 | KDM4E (0.58) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL7517153 | 0.80 | MAPT (0.58) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL15700133 | 0.79 | CYP19A1 (0.67) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL9361537 | 0.78 | MAPT (0.59) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL7772416 | 0.78 | KDM4E (0.62) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL7526340 | 0.77 | DDB1 (0.44) | MAPTKDM4ELMNAPOLBCYP19A1 | |
| SCHEMBL5761402 | 0.77 | PARP10 (0.49) | MAPTKDM4ELMNAPOLBACHE | |
| SCHEMBL7777529 | 0.77 | MAPT (0.64) | MAPTKDM4ELMNAPOLBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4265613-A1 | BENZENE RING COMPOUND AND USE THEREOF | Nanjing Shijiang Medicine Technology Co., Ltd (CN) | 2023-10-25 | — | — | EP | disclosed |
| WO-2010021149-A1 | SPIRO COMPOUND CAPABLE OF INHIBITING ACID SECRETION | 武田薬品工業株式会社 (JP) | 2010-02-25 | — | — | WO | disclosed |
| EP-0851862-B1 | 1(HETERO)ARYL-4-(CONDENSED THIAZOL-2-YLALKYL)-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF 5-HT1A-RECEPTOR MEDIATED DISORDERS | PHARMACIA ITALIA SPA (IT) | 2003-09-10 | — | — | EP | disclosed |
| US-5834499-A | TREATING GASTROINTESTINAL DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1998-11-10 | — | — | US | disclosed |
| EP-0851862-A1 | 1(HETERO)ARYL-4-(CONDENSED THIAZOL-2-YLALKYL)-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF 5-HT1A-RECEPTOR MEDIATED DISORDERS | Pharmacia Italia S.p.A. (IT) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997008159-A1 | 1(HETERO)ARYL-4-(CONDENSED THIAZOL-2-YLALKYL)-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF 5-HT1A-RECEPTOR MEDIATED DISORDERS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-03-06 | — | — | WO | disclosed |
| EP-0749966-A1 | 5-HT 3 RECEPTOR AGONIST, NOVEL THIAZOLE DERIVATIVE, AND INTERMEDIATE THEREFOR | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1996-12-27 | — | — | EP | disclosed |
| US-5565479-A | IMIDAZOLYL FUSED THIAZOLES ANTISEROTONINE AGENT | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1996-10-15 | — | — | US | disclosed |
| EP-0666263-A1 | NOVEL CONDENSED THIAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1995-08-09 | — | — | EP | disclosed |
| US-3954983-A | CENTRAL NERVOUS SYSTEM ANTIDEPRESSANTS | RICHARDSON-MERRELL INC. (US) | 1976-05-04 | — | — | US | disclosed |